ALEXION PHARMACEUTICALS, INC.

ALEXION PHARMACEUTICALS, INC. logo
🇺🇸United States
Ownership
Public, Subsidiary
Established
1992-01-01
Employees
3.8K
Market Cap
-
Website
http://www.alexion.com

Safety, Tolerability, and Efficacy of 12-weeks of Sovaprevir, ACH-3102, and Ribavirin in Treatment-naive GT-1 HCV Participants

First Posted Date
2013-05-08
Last Posted Date
2023-08-29
Lead Sponsor
Alexion Pharmaceuticals, Inc.
Target Recruit Count
30
Registration Number
NCT01849562

The Safety and Efficacy of Eculizumab in Japanese Patients With Atypical Hemolytic Uremic Syndrome (aHUS)

Phase 2
Completed
Conditions
Interventions
First Posted Date
2012-12-31
Last Posted Date
2017-03-10
Lead Sponsor
Alexion Pharmaceuticals, Inc.
Target Recruit Count
2
Registration Number
NCT01757431
Locations
🇯🇵

Nagano Red Cross Hospital, Nagano, Japan

🇯🇵

Tokyo Medical and Dental University Hospital, Tokyo, Japan

Acid Lipase Replacement Investigating Safety and Efficacy (ARISE) in Participants With Lysosomal Acid Lipase Deficiency

First Posted Date
2012-12-28
Last Posted Date
2020-12-29
Lead Sponsor
Alexion Pharmaceuticals, Inc.
Target Recruit Count
66
Registration Number
NCT01757184

To Characterize the Safety and Tolerability of Eculizumab in Two Japanese aHUS Patients

First Posted Date
2012-12-24
Last Posted Date
2012-12-24
Lead Sponsor
Alexion Pharmaceuticals, Inc.
Target Recruit Count
2
Registration Number
NCT01755429
Locations
🇯🇵

Tokyo Medical and Dental University, Tokyo, Japan

🇯🇵

Shinshu University School of Medicine, Matsumoto, Japan

Safety & Efficacy Of Eculizumab In The Prevention Of AMR In Sensitized Recipients Of A Kidney Transplant From A Deceased Donor

Phase 2
Completed
Conditions
Interventions
First Posted Date
2012-03-30
Last Posted Date
2019-05-03
Lead Sponsor
Alexion Pharmaceuticals, Inc.
Target Recruit Count
80
Registration Number
NCT01567085

An Observational Study of Patients With Lysosomal Acid Lipase Deficiency/Cholesteryl Ester Storage Disease Phenotype

First Posted Date
2012-02-08
Last Posted Date
2016-07-20
Lead Sponsor
Alexion Pharmaceuticals, Inc.
Target Recruit Count
49
Registration Number
NCT01528917
Locations
🇺🇸

Morgan Stanley Children's Hospital of New York-Presbyterian, New York, New York, United States

🇺🇸

Stanford University, Stanford, California, United States

🇺🇸

Children's Hospital of Pittsburgh, Pittsburgh, Pennsylvania, United States

and more 13 locations

aHUS Observational Long Term Follow-Up

First Posted Date
2012-01-31
Last Posted Date
2017-02-24
Lead Sponsor
Alexion Pharmaceuticals, Inc.
Target Recruit Count
94
Registration Number
NCT01522170
Locations
🇺🇸

Emory Healthcare - Children's Center, Atlanta, Georgia, United States

🇺🇸

Boston Children's Hospital, Boston, Massachusetts, United States

🇺🇸

Dunwoody Pediatrics & Children's Healthcare of Atlanta, Dunwoody, Georgia, United States

and more 52 locations
© Copyright 2024. All Rights Reserved by MedPath